Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro

Research output: Contribution to journalArticlepeer-review

Abstract

Inflammation is involved in the pathology of Parkinson's disease, a disorder characterised by degeneration of dopaminergic neurons. This study demonstrates that conditioned medium (CM) from lipopolysaccharide (LPS)-treated rat glial-enriched cortical cultures induced death of embryonic rat dopaminergic neurons in vitro, an effect which was additive to the toxicity of the neurotoxin 6-hydroxydopamine. Interleukin-1β (IL-1β) in the CM may mediate this neuronal death. IL-1R1 was found to be expressed on dopaminergic neurons. Blockade of IL-1R1 prevented CM-induced dopaminergic neuronal death. This study suggests that IL-1β in CM from LPS-stimulated glia contributes to dopaminergic neuronal death induced by glia-conditioned medium.

Original languageEnglish
Pages (from-to)20-26
Number of pages7
JournalJournal of Neuroimmunology
Volume226
Issue number1-2
DOIs
Publication statusPublished - Sep 2010

Keywords

  • 6-hydroxydopamine
  • Dopaminergic neuron
  • IL-1 receptor, type 1
  • Inflammation
  • Interleukin-1 receptor antagonist
  • Parkinson's disease

Fingerprint

Dive into the research topics of 'Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro'. Together they form a unique fingerprint.

Cite this